Innovative cancer therapies start here

Committed to the development of innovative therapies for human and veterinary oncology applications, we are currently developing our main drug candidate ET-D5 for both applications simultaneously. In addition, we have several other R&D programs currently in the discovery phase.

Our Pipeline

ET-D5

Developing innovative therapies to improve patient life is our primary mission. We care about you.

Our technology platform

We use our proprietary phenotypic screening platform to discover new effective drugs.